- Consumer Products
- Latest 1.70
- Currency US$
- Change -0.02
- Percent Change -1.163 %
- Volume 7,171,014
- Fri Sep 19, 2014 12:15 PM EDT NASDAQ data delayed 15 minutes.
12 months ended Mar 31, 2014.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Jul 31||$-0.39||Oct 29||$-0.34|
12 months ended Sep 20, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
Exelixis Inc. is a leader in the fields of model system genetics and comparative genomics. These fields involve the systematic study of simple organisms, such as fruit flies, nematodes, mice, zebrafish and simple plants, to rapidly and efficiently determine gene function and establish its commercial utility in humans and other commercially important biological systems. The proprietary technologies provide a rapid, efficient and cost-effective way to move beyond DNA sequence data to understand the function of genes and the proteins that they encode.